The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon
Work +49 40 85 301 0
Fax +49 40 85 301 511

Germany: Industry focus

Healthcare and life sciences
Healthcare and life sciences - ranked: tier 3

Möhrle Happ Luther

Möhrle Happ Luther’s expertise centres on drug advertising law, Amnog and compliance matters. The client portfolio predominantly consists of pharmaceutical companies but also includes medical device manufacturers and service providers. The team has additional experience advising start-ups; key figures are Henning Anders, Julia Luther and Martin Luther. Anders successfully obtained a declaration of the unlawfulness of a decision of the German Federal Joint Committee concerning the benefit analysis of the drug Linaclotid for Almirall at the Higher Social Court of Berlin-Brandenburg. The group advises longstanding client AstraZeneca on pharmaceutical law and drug advertising law matters. Other clients include Novartis, Allergan and Amgen.

[back to top]

Germany: Real estate and construction

Real estate
Real estate - ranked: tier 5

Möhrle Happ Luther

The four-strong team at Möhrle Happ Luther is ‘very efficient’ and ‘highly recommended for complex matters’ including transactions, project development and tenancy law matters. ‘Well-versed transaction lawyer’ Anne Schöning and the ‘internationally experienced’ Oliver Reimann advised a German real estate company on the acquisition and project development of an office and retail building in Berlin, while Simon Golshan assisted Magna Asset Management with the acquisition of a residential project by way of a forward share deal. It regularly advises HafenCity Hamburg on the sale of construction fields.

[back to top]

Further information on Möhrle Happ Luther

Please choose from this list to view details of what we say about Möhrle Happ Luther in other jurisdictions.


Offices in Hamburg

Legal Developments in Germany

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to